| Financial Year |
March 31 2023 |
| Monetary Funds |
914,854,119.53 |
| Held-for-trading Financial Assets |
1,587,409,013.74 |
| Notes Receivable |
628,763,118.48 |
| Accounts Receivable |
735,505,457.86 |
| Advances to Suppliers |
102,340,068.78 |
| Other Receivables |
19,588,868.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
656,574,140.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
322,748,664.38 |
| Other Current Assets |
11,163,170.65 |
| Total Current Assets |
5,058,311,975.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,949,684.70 |
| Investment Properties |
5,107,560.55 |
| Fixed Assetes |
1,226,964,094.24 |
| Under-construction Projects |
207,533,646.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,642,694.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,120,753.25 |
| Deferred Income Tax Assets |
88,159,002.54 |
| Other Non-Current Assets |
339,234,434.31 |
| Sub-Total of Non-Current Assets |
2,107,491,958.67 |
| Total Assets |
7,165,803,934.34 |
| Short-Term Loans |
52,488,275.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
406,559,423.43 |
| Accounts Received In Advance |
275.00 |
| Employee Compensation Payable |
85,507,903.52 |
| Taxes Payable |
64,824,971.02 |
| Interest Payable |
-- |
| Dividend Payable |
1,662,996.00 |
| Other payables |
339,833,119.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
299,764.07 |
| Other Current Liabilities |
443,550,026.06 |
| Sub-Total of Current Liabilities |
1,469,750,696.71 |
| Long-term Loans |
100,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,181,184.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
179,981,510.40 |
| Total Liabilities |
1,649,732,207.11 |
| Paid-In Capital(Or Share Stock) |
453,263,000.00 |
| Capital Surplus |
1,915,372,023.03 |
| Surplus Reserve |
226,676,500.00 |
| LESS:Treasury Stock |
19,347,064.24 |
| Undistributed Profits |
2,917,802,578.84 |
| Minority Stockholder's Interest |
25,221,816.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,490,849,910.78 |
| Owner's Equity（Stockholder's Equity） |
5,516,071,727.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,165,803,934.34 |
